Roche’s new influenza drug Xofluza can dramatically prevent the spread of the virus when used as a preventive therapy, according to new phase 3 data. Xofluza (baloxavir marboxil) is already ...

But what kind of sickness do your symptoms point to? Here's a breakdown for COVID-19, flu and more — and why testing is so ...

Fortunately, most people with the flu feel better within about a week of their symptoms beginning. Nonetheless, the average ...

The FDA has approved a new use for Xofluza (baloxavir marboxil) from Roche’s Genentech unit, to prevent people developing flu after coming into contact with an infectious person.

Discover the similarities between Covid, flu, and the common cold, and learn how to diagnose each one accurately with testing ...

In the man-bug arms race, this alarming fact seems to have been confirmed with Xofluza, the brand name of a new antiviral medication for the treatment of influenza A and influenza B. Xofluza ...

Roche announced positive topline results of the phase III CENTERSTONE study of Xofluza (baloxavir marboxil), an antiviral, showing a reduction in the transmission of influenza viruses. The study met ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members – – This is the first time that any antiviral used in the ...